Joseph P Contino, MD

Dr. Joseph P Contino, MD

[National Cancer Institute @theNCI]

In women with early-stage breast cancer, both whole- and partial-breast radiation therapy can reduce the risk of the cancer returning after breast-conserving surgery: https://t.co/nsFVjSEgb3 #CancerCurrents

[Annals of Surgical Oncology @AnnSurgOncol]

JULY ISSUE: Biopsy Feasibility Trial for #BreastCancer Pathologic Complete Response Detection after #NeoadjuvantChemotherapy: Imaging Assessment and Correlation Endpoints. https://t.co/qQLdWgzsMP @McMastersKelly @SocSurgOnc

[Paul Thiruchelvam 🇺🇦 @1LondonBreast]

Significant variation in surgeon acceptance of more limited surgery for breast cancer. Potential for over treatment in lower volume breast surgeons. #breastcancer #bcsm @JAMAOnc @ASBrS @ABSGBI

[Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO @ASCOPres]

.@ASCO strongly opposes proposed cuts to the 2019 Medicare Physician Fee Schedule that would further limit resources for providing high-quality cancer care. We urge @CMSGov to abandon this proposal and support robust access to #cancer care https://t.co/NPlxX2Ktp6

[Joseph P Contino, MD @Doccontino]

Again today wonderful debates#ASBrS18

[Joseph P Contino, MD @Doccontino]

Two excellent debates to end the afternoon session#ASBrs18

[Joseph P Contino, MD @Doccontino]

@kimberli_coxmd @DrAttai @ASBrS Especially when considering pathology and radiology support

[Joseph P Contino, MD @Doccontino]

@ASBrS And yet so many patients still go unscreened and it’s not about poor access.

[Judy Boughey @DrJudyBoughey]

#ASBrS18 ASBrS publications committee meeting. Great science at this years meeting. My last year as publications committee chair. Thank you all. What an awesome hard working group of people. @HenryKuerer @DrZAlHilli @DrJDietz @ptrthiru

[ASBrS @ASBrS]

Study shows modern lumpectomy treatment significantly reduces of breast cancer recurrence compared to older treatment protocols - Choosing to keep a breast is safer than ever before #ASBrS18 https://t.co/eXykqpBl1Q

[ASBrS @ASBrS]

Breast cancer genetic testing guidelines exclude almost half of high-risk patients: New research shows current restrictive genetic testing guidelines bar many patients with high-risk breast cancer mutations: https://t.co/TTG3qxQZ71 #ASBrS18

[Joseph P Contino, MD @Doccontino]

This month’s Selected Readings CME is on repeat sentinel lymph node biopsy in breast cancer recurrence. #ASBRS

[Joseph P Contino, MD @Doccontino]

This month the Selected Readings CME offers two separate 1 credit education activities for members @#ASBrS

[Annals of Surgical Oncology @AnnSurgOncol]

EDITORUAL: Changing Dogma and Decreased Collateral Damage in #BreastCancer Care. https://t.co/pljVtNcxv4

[Annals of Surgical Oncology @AnnSurgOncol]

OCTOBER ISSUE: Contralateral #BreastCancer Risk in Women w/ DCIS: Is it High Enough to Justify #BilateralMastectomy? https://t.co/zRIGjYBbLx

[Annals of Surgical Oncology @AnnSurgOncol]

OCTOBER ISSUE: Challenging Atypical #BreastLesions - Flat Epithelial Atypia,# RadialScar,& #IntraductalPapilloma. https://t.co/zaYK3f3KjS

[Annals of Surgery @AnnalsofSurgery]

Readiness of US General Surgery Residents for Independent Practice https://t.co/Petzl0Rs0t #VisualAbstract #meded

[Annals of Surgical Oncology @AnnSurgOncol]

OCTOBER ISSUE: A Validated Nomogram to Predict Upstaging of #DuctalCarcinomainSitu to Invasive Disease https://t.co/7JGlUQe6Tn

[National Cancer Institute @theNCI]

Large study confirms estimates of the risk of developing cancer for women with inherited mutations in the BRCA genes https://t.co/r3rsAvIsi0

[Joseph P Contino, MD @Doccontino]

The last paragraph is a key point to consider for all. https://t.co/KgNewAaPUK